BNP/CALL/ASTRAZENECA/13000/0.1/20.06.25 Stock

Warrant

DE000PC8HB68

Market Closed - Börse Stuttgart 04:12:59 2024-05-31 am EDT
1.2 EUR +2.56% Intraday chart for BNP/CALL/ASTRAZENECA/13000/0.1/20.06.25
Current month+1.69%
1 month+1.69%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 1.2 +2.56%
24-05-30 1.17 -0.85%
24-05-29 1.18 -7.81%
24-05-28 1.28 -5.88%
24-05-24 1.36 -2.16%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 04:12 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC8HB6
ISINDE000PC8HB68
Date issued 2024-04-17
Strike 13,000 p
Maturity 2025-06-20 (384 Days)
Parity 10 : 1
Emission price 0.54
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.4
Lowest since issue 0.64
Delta0.53x
Omega 5.894
Premium15.4x
Gearing11.16x
Moneyness 0.9395
Difference Strike 810 p
Difference Strike %+6.23%
Spread 0.01
Spread %0.78%
Theoretical value 1.285
Implied Volatility 23.17 %
Total Loss Probability 56.62 %
Intrinsic value 0.000000
Present value 1.285
Break even 14,094.78 €
Theta-0.02x
Vega0.06x
Rho0.07x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
155.1 USD
Average target price
172 USD
Spread / Average Target
+10.90%
Consensus